A Case Report of Kidney Graft Failure after Duodenal Bypass Surgery.
- Author:
Ha Neul KIM
1
;
Yul Hee CHO
;
Young Shin KIM
;
Hyun Ji CHUN
;
Su Jin CHOI
;
Eun Oh KIM
;
Chul Woo YANG
Author Information
1. Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea. yangch@catholic.ac.kr
- Publication Type:Case Report
- Keywords:
Tacrolimus;
Immunosuppressant;
Duodenal bypass;
Renal transplantation;
Acute rejection
- MeSH:
Absorption;
Adult;
Calcineurin;
Cholangiopancreatography, Endoscopic Retrograde;
Duodenum;
Female;
Gastric Bypass;
Gastrointestinal Tract;
Humans;
Kidney;
Kidney Transplantation;
Pancreatitis;
Rejection (Psychology);
Tacrolimus;
Tissue Donors;
Transplantation, Homologous;
Transplants
- From:Korean Journal of Medicine
2012;83(3):369-372
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The calcineurin inhibitor-immunosuppressant tacrolimus is widely used in patients undergoing kidney transplantation. Although tacrolimus is absorbed from the entire gastrointestinal tract, the duodenum is the primary site of its absorption and metabolism. Therefore, duodenal bypass surgery in a renal transplant recipient can significantly disrupt tacrolimus absorption and metabolism. Here, we report a case of allograft failure that developed after duodenal bypass surgery. The patient was a 41-year-old woman who received a deceased donor kidney transplantation. She underwent a gastrojejunostomy due to a duodenal perforation and pancreatitis after endoscopic retrograde cholangiopancreatography. After the surgery, her blood tacrolimus level decreased gradually, and remained lower than therapeutic target levels, even after the tacrolimus dose was increased from 5 to 12 mg/day. Repetitive rejection developed and the patient suffered allograft failure 3 months after bypass surgery. This case raises the importance of drug absorption in renal transplant recipients undergoing duodenal bypass surgery.
